A large multicenter study provides further evidence supporting the rationale for multidisciplinary teams for cardiogenic shock, one of the most lethal diseases in cardiovascular medicine. The analysis of 24 critical care ICUs (CICUs) in the Critical Care Cardiology Trials Network…
Read More
FDA Approves Tacrolimus for Lung Transplants
The US Food and Drug Administration (FDA) has approved the use of the transplant drug tacrolimus (Progaf) for the prevention of organ rejection in adult and pediatric patients receiving lung transplants. This is the only immunosuppressant drug approved for this…
Read More